# Review Finds Cannabis Compounds Show Strong Anticancer > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-compounds-anticancer-effects-cervical-cancer/ > **Published:** 2026-08-26T17:35:19-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:46:44-04:00 > **Clinical Summary:** Explore cannabis compounds anticancer effects cervical cancer cells, highlighting CBD and THC's potential in oncology research and treatment development. --- ✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CancerResearchCBDTHCNeurologyHempSafety Why This Matters This article matters for clinicians and their patients as it presents evidence of anticancer effects of [cannabis compounds](https://cedclinic.com/cannabis-terpene-synergy-entourage-effect/), specifically CBD and THC, against cervical cancer cells. If further research confirms these findings, they could potentially contribute to new treatment options in oncology, impacting [clinical practice](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/) significantly. Understanding the mechanisms involved, such as oxidative stress, may also aid in tailoring [cannabis-based therapies](https://cedclinic.com/cannabinoids-inhibit-keratinocyte-proliferation-non-cb1-cb2/) for cancer patients. Clinical Summary In a recent study, [cannabis compounds](https://cedclinic.com/cannabis-terpene-synergy-entourage-effect/) such as cannabidiol (CBD) and tetrahydrocannabidiol (THC) demonstrated potent anticancer effects against cervical cancer cells by inducing oxidative stress. These findings suggest that these compounds may have potential therapeutic applications in the treatment of cervical cancer, warranting further investigation into their clinical implications for patients and the development of targeted therapies. Dr. Caplan’s Take “These findings, derived from peer-reviewed research on human subjects, indicate a promising potential for [cannabis compounds](https://cedclinic.com/cannabis-terpene-synergy-entourage-effect/) like CBD and THC in the fight against cervical cancer. However, it’s crucial to emphasize that while these results are encouraging, further [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) are necessary to fully understand their efficacy and safety in cancer treatment.” – [Dr. Benjamin Caplan](https://cedclinic.com/cannabis-halloween-safety/), MD Clinical Perspective 🔬 A recent review suggests promising anticancer effects of [cannabis compounds](https://cedclinic.com/cannabis-terpene-synergy-entourage-effect/), specifically CBD and THC, against cervical cancer cells. These findings indicate potential mechanisms involving oxidative stress, implying a role for reactive oxygen species (ROS). However, it’s crucial to acknowledge the complexity of this area, as research on cannabis in oncology is still evolving. Confounders such as interactions with other treatments and individual variability in response should be considered. In [clinical practice](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/), these findings could potentially open new avenues for cervical cancer treatment, but further research is needed to confirm the safety and efficacy of [cannabis-based therapies](https://cedclinic.com/cannabinoids-inhibit-keratinocyte-proliferation-non-cb1-cb2/) in this context. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Review%20Finds%20Cannabis%20Compounds%20Show%20Strong%20Anticancer%20Effects%20Against%20Cervical%20Cancer%20Cells%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D74908)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D74908)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Review%20Finds%20Cannabis%20Compounds%20Show%20Strong%20Anticancer%20Effects%20Against%20Cervical%20Cancer%20Cells%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D74908)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) 📰 Source: [https://themarijuanaherald.com/2026/08/review-finds-cannabis-compounds-show-strong-anticancer-effects-against-cervical-cancer-cells/amp/](https://themarijuanaherald.com/2026/08/review-finds-cannabis-compounds-show-strong-anticancer-effects-against-cervical-cancer-cells/amp/) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Symptoms improve for cancer patients after cannabis extract use, study finds – leafie](https://cedclinic.com/symptoms-improve-for-cancer-patients-after-cannabis-extract-use-study-finds-leafie/) Study reveals symptom improvements in cancer patients using cannabis extracts, highlighting potential benefits in oncology care. [Read Study Insights](https://cedclinic.com/symptoms-improve-for-cancer-patients-after-cannabis-extract-use-study-finds-leafie/) [Cannabis Seed Compounds May Protect Nerve Cells From Parkinson’s-Related Damage …](https://cedclinic.com/cannabis-seed-compounds-may-protect-nerve-cells-from-parkinsons-related-damage/) Research on cannabis seed compounds shows neuroprotective effects, expanding understanding of cannabis in disease treatment. [Explore Neuroprotection](https://cedclinic.com/cannabis-seed-compounds-may-protect-nerve-cells-from-parkinsons-related-damage/) [New Clinical Insights on Cannabis and Patient Outcomes](https://cedclinic.com/new-clinical-insights-on-cannabis-and-patient-outcomes/) Latest clinical insights reveal how cannabis impacts patient outcomes across various conditions, informing [clinical practice](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/). [Discover Clinical Insights](https://cedclinic.com/new-clinical-insights-on-cannabis-and-patient-outcomes/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).